Tributary Capital Management LLC Buys 115,122 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

Tributary Capital Management LLC raised its holdings in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 54.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 325,567 shares of the technology company's stock after acquiring an additional 115,122 shares during the period. Tributary Capital Management LLC owned approximately 1.63% of Simulations Plus worth $10,425,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. nVerses Capital LLC raised its stake in Simulations Plus by 1,100.0% during the 3rd quarter. nVerses Capital LLC now owns 1,200 shares of the technology company's stock valued at $38,000 after acquiring an additional 1,100 shares in the last quarter. EntryPoint Capital LLC bought a new stake in Simulations Plus during the 1st quarter valued at $57,000. Allspring Global Investments Holdings LLC bought a new stake in Simulations Plus during the 1st quarter valued at $70,000. Los Angeles Capital Management LLC bought a new stake in Simulations Plus during the 2nd quarter valued at $206,000. Finally, Arizona State Retirement System bought a new stake in Simulations Plus during the 2nd quarter valued at $218,000. Institutional investors own 78.08% of the company's stock.

Insiders Place Their Bets

In other news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $35.18, for a total value of $703,600.00. Following the transaction, the director now directly owns 3,501,592 shares in the company, valued at approximately $123,186,006.56. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders sold 60,750 shares of company stock valued at $2,145,055 over the last quarter. Insiders own 20.90% of the company's stock.

Simulations Plus Price Performance

SLP traded up $0.22 during trading on Monday, reaching $30.90. 245,144 shares of the stock traded hands, compared to its average volume of 130,630. The stock has a market cap of $618.31 million, a price-to-earnings ratio of 63.65 and a beta of 0.69. Simulations Plus, Inc. has a fifty-two week low of $29.37 and a fifty-two week high of $51.22. The stock's 50-day simple moving average is $33.08 and its two-hundred day simple moving average is $40.50.

Simulations Plus (NASDAQ:SLP - Get Free Report) last announced its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, topping analysts' consensus estimates of $0.04 by $0.02. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The company had revenue of $18.70 million during the quarter, compared to analysts' expectations of $19.73 million. During the same quarter in the previous year, the firm earned $0.18 earnings per share. The business's quarterly revenue was up 19.9% compared to the same quarter last year. Research analysts anticipate that Simulations Plus, Inc. will post 1.14 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on SLP shares. Craig Hallum reiterated a "buy" rating and set a $56.00 price target on shares of Simulations Plus in a research report on Wednesday, July 3rd. William Blair reiterated an "outperform" rating on shares of Simulations Plus in a research report on Thursday. KeyCorp started coverage on Simulations Plus in a research report on Monday, July 29th. They set an "overweight" rating and a $47.00 price target on the stock. JMP Securities initiated coverage on Simulations Plus in a report on Tuesday, July 16th. They set a "market perform" rating on the stock. Finally, BTIG Research reduced their price objective on Simulations Plus from $60.00 to $50.00 and set a "buy" rating for the company in a research report on Thursday. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $54.50.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.